Insider · CIK 0001635393

Daly Richard J

Reports to the SEC for 4 companies · CORAL GABLES, FL

sec.gov

Transactions

Companies

Filings

CIK

0001635393

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockD Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−491K sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsD Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−115K sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockD Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−30K sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockD Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−382K sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockD Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−15K sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockD Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−1.37M sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockD Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−20K sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC.D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−271K sh	$31.50	−$8.54M	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsD Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−40K sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsD Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−126K sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockD Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−33.5K sh	—	—	0
2026-01-05	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−42.1K sh	—	—	2,618,539
2026-01-05	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+42.1K sh	—	—	281,843
2026-01-05	CPRXCATALYST PHARMACEUTICALS, INC.F Tax Payment	Director, President and CEO	FTax Payment	−10.6K sh	—	—	271,266
2025-12-29	CPRXCATALYST PHARMACEUTICALS, INC.F Tax Payment	Director, President and CEO	FTax Payment	−524 sh	—	—	239,738
2025-12-29	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+1,334 sh	—	—	240,262
2025-12-29	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−1,334 sh	—	—	2,660,644
2025-11-21	CPRXCATALYST PHARMACEUTICALS, INC.F Tax Payment	Director, President and CEO	FTax Payment	−7,872 sh	—	—	238,928
2025-11-21	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+20K sh	—	—	246,800
2025-11-21	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−20K sh	—	—	2,661,978
2025-11-20	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director, President and CEO	AAward	+115K sh	—	—	2,681,984
2025-11-20	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockA Award	Director, President and CEO	AAward	+382K sh	—	—	2,546,695
2025-08-26	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+50K sh	$2.24	+$112K	249,764
2025-08-26	CPRXCATALYST PHARMACEUTICALS, INC.S Sale	Director, President and CEO	SSale	−23K sh	$20.62	−$474K	226,794
2025-08-26	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−50K sh	—	—	2,184,753
2025-05-30	CPRXCATALYST PHARMACEUTICALS, INC.S Sale	Director, President and CEO	SSale	+70K sh	$24.86	+$1.74M	199,764
2025-02-14	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+4,000 sh	—	—	271,338
2025-02-14	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−4,000 sh	—	—	2,234,753
2025-02-14	CPRXCATALYST PHARMACEUTICALS, INC.F Tax Payment	Director, President and CEO	FTax Payment	−1,574 sh	—	—	269,764
2025-01-02	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−42.1K sh	—	—	2,238,753
2025-01-02	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+42.1K sh	—	—	277,938
2025-01-02	CPRXCATALYST PHARMACEUTICALS, INC.F Tax Payment	Director, President and CEO	FTax Payment	−10.6K sh	—	—	267,338
2024-12-27	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−1,333 sh	—	—	2,280,858
2024-12-27	CPRXCATALYST PHARMACEUTICALS, INC.F Tax Payment	Director, President and CEO	FTax Payment	−324 sh	—	—	235,833
2024-12-27	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+1,333 sh	—	—	236,157
2024-11-21	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director, President and CEO	AAward	+60K sh	—	—	2,282,191
2024-11-21	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockA Award	Director, President and CEO	AAward	+491K sh	—	—	2,222,172
2024-06-04	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−40K sh	—	—	1,731,012
2024-06-04	CPRXCATALYST PHARMACEUTICALS, INC.S Sale	Director, President and CEO	SSale	−17.3K sh	$15.97	−$277K	234,824
2024-06-04	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+40K sh	$4.01	+$160K	252,147
2024-02-15	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director, President and CEO	AAward	−4,000 sh	—	—	1,771,012
2024-02-15	CPRXCATALYST PHARMACEUTICALS, INC.F Tax Payment	Director, President and CEO	FTax Payment	−1,186 sh	—	—	212,147
2024-02-15	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+4,000 sh	—	—	213,333
2024-01-01	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockA Award	Director, President and CEO	AAward	+1.37M sh	—	—	1,564,486
2024-01-01	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director, President and CEO	AAward	+211K sh	—	—	1,775,012
2023-12-27	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+1,333 sh	—	—	209,333
2023-12-27	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−1,333 sh	—	—	199,167
2023-12-07	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−60K sh	—	—	200,500
2023-12-07	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+60K sh	$1.13	+$67.8K	208,000
2023-05-12	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−50K sh	—	—	260,500

Recent filings

Accepted (ET)
Jul 174
Daly Richard J0001161697-26-000173
SEC(opens sec.gov)
Jan 64
Daly Richard J0001161697-26-000021
SEC(opens sec.gov)
Dec 304
Daly Richard J0001161697-25-000488
SEC(opens sec.gov)
Nov 244
Daly Richard J0001161697-25-000413
SEC(opens sec.gov)

Companies

Address

355 ALHAMBRA CIRCLE SUITE 801

CORAL GABLES, FL, 33134